News Overview

Record date is 23 February 2022

Record date is 23 February 2022

The joint venture will provide SES’s satellite data and connectivity services in India, except for certain international aeronautical and maritime customers who may be served by SES.

The benchmark indices suffered substantial losses, as the market make a weak start to the week following rising tensions between Ukraine and Russia. Oil prices have spiked to 7-year highs. The Nifty managed to hold its psychological 17,000 mark. At 9:30 IST, the barometer index, the S&P BSE Sensex, slumped 1,218.56 points or 2.10% at 56,934.36. The Nifty 50 index dropped 363.45 points or 2.09% […]

UFlex jumped 8.04% to Rs 550 after the companys consolidated net profit rose 95.85% to Rs 313.21 crore on 63.46% rise in net sales to Rs 3387.76 crore in Q3 December 2021 over Q3 December 2020.

With effect from 12 February 2022

Record date is 25 February 2022

For Fund-based working capital limits, Rs5 billion IND AA-/Stable/IND A1+ rating has been affirmed.

In Q3FY22, the company touched an all-time high retail disbursement of Rs1,456 crore for a quarter, and collection efficiencies remained above 100%.

Zydus U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received final approval from the USFDA to market Roflumilast Tablets in the strength of 500 mcg and a tentative approval for Roflumilast Tablets, 250 mcg (US RLD – DALIRESP?). Zydus being one of the first applicants for Roflumilast Tablets, 500 mcg is eligible for 180 days of shared generic drug exclusivity under section 505(j)(5)(B)(iv) of the FD&C […]